Welcome to the Jason Carter Clinical Trials Website
Our website helps patients find clinical trials. We currently offer patient-friendly descriptions of leukemia and lymphoma trials. Early in 2018, we will be:
Adding patient-friendly trial descriptions for other blood cancers and disorders
Making improvements to the search tool
Expanding our educational resources
Didn't find a trial or need help? Contact our clinical trial specialist at 888-814-8610 or contact@ctsearchsupport.org.
If DSP-5336 is safe and works well to treat acute leukemia that has relapsed or is refractory
You may be able to join this trial if you:
Are 18 years old or older
Have one of the following:
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Do not have acute promyelocytic leukemia
Do not have untreated lymphoma in your brain or spinal cord
Have not had a blood or marrow transplant (BMT) or cell therapy in the last 2 months.
Agree to have other standard tests done to see if you can be in the clinical trial
Trial Details
DSP-5336 is a small molecule inhibitor that blocks the menin-MLL interaction in certain cells.
You’ll get:
DSP-5336 – A pill that you take by mouth. The dose you'll get depends on when you start the trial and how safe it has been
You may continue treatment for as long as the clinical trial doctors think it’s best for your health. You'll have biopsies to see how well the treatment is working.
The Food and Drug Administration (FDA) has not yet approved DSP-5336.
